Zacks Research Analysts Increase Earnings Estimates for AGIO
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research lifted their Q2 2025 EPS estimates for shares of Agios Pharmaceuticals in a report released on Thursday, May 22nd. Zacks Research analyst A. Chakraborty now expects that the biopharmaceutical company will post earnings per share of ($1.77) for the quarter, up from their […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research lifted their Q2 2025 EPS estimates for shares of Agios Pharmaceuticals in a report released on Thursday, May 22nd. Zacks Research analyst A. Chakraborty now expects that the biopharmaceutical company will post earnings per share of ($1.77) for the quarter, up from their […]
